Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Candel Therapeutics granted inducement stock options to two new employees for an aggregate of 29,400 shares at an exercise price of $6.18 per share. The grants were approved by the Compensation Committee on April 30, 2026, under the Company's 2025 Inducement Plan and Nasdaq Listing Rule 5635(c)(4).
Key figures
- Offering Price
- 6.18
- Shares Offered
- 29400
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.